Skip to content

DR. GEERT PAGE

Active
Private limited companyfounded 2001active for 25 yearsGasthuisstraat 59, 8970 Poperinge, BelgiumKBO/BCE: BE 0474.796.588
Summary

DR. GEERT PAGE has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €651,347 and a net result of €42,816. Equity remains stable across the filed financial years (±1.7% per year). Its solvency ranks better than 29% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DR. GEERT PAGEActiveChecked score 91/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
7th oldest company in Poperinge, Health and social work sector1 site
Size
€1.9mtotal assets 2025
Staff
0.1 FTE
Equity
€651,347
Profit
€42,816
Turnover not published (micro format)
Financial health
91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 59 days early1 of 4 deeds summarised
Why 91lowers riskSector: Human health activities (NACE 86)Size: total assets €1.9mFigures for financial year 2025 (filed 03-06-2026)Liquidity: current ratio 0.87, cash €458,340Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 28% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 60-5
equity 34.9% of total assets
Liquidity 69-2
short-term debt 28.7% · cash 24.5%
Profitability 50-23
return on assets 2.3%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,117 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026highest value 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €55,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.87, compared with 1.01 in 2024, below 1; short-term debt: 28.7% and cash: 24.5% of total assets), and 65.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 29% on solvency, 49% on liquidity, 8% on profitability and 24% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €1.9m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 03-06-2026)
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.87, cash €458,340
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-06-2026, 59 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
59 days early
2024
59 days early
2023
58 days early
2022
77 days early
2021
41 days early
2020
47 days early
2019
25 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 52 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 2 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Annual accounts filedfinancial year 2023 · micro…

Key points

  • Positive: Among the best 13% on equitysector median €124,488 · 20,600 companies €651,347 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€1.9m
Profit
€42,816
Solvency
34.9%
Total assets▼ 1.6%
Net result
20182025
Go to Financials

Timeline

Events
32
Since
2002
Next accounts
by 31-07-2027
  1. 31-12-2023Back to profit
  2. 30-08-2023Appointment: Page Geert (director)
  3. 15-05-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
15-05-2001
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about DR. GEERT PAGE

What is the company number of DR. GEERT PAGE?
0474.796.588. In Belgium the VAT number is the company number with BE in front: BE 0474.796.588.
Where is DR. GEERT PAGE based?
The registered office is at Gasthuisstraat 59, 8970 Poperinge.Company details
What does DR. GEERT PAGE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. GEERT PAGE?
Private limited company (BV).
When was DR. GEERT PAGE founded?
On 15-05-2001.
Is DR. GEERT PAGE still active?
Yes, DR. GEERT PAGE is an active enterprise in the KBO register.
How many employees does DR. GEERT PAGE have?
On average 0.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of DR. GEERT PAGE?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is DR. GEERT PAGE profitable?
In financial year 2025, DR. GEERT PAGE made a profit of €42,816.
Where can I find the annual accounts of DR. GEERT PAGE?
DR. GEERT PAGE filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. GEERT PAGE due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DR. GEERT PAGE

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure